[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.204.52.4. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 1,474
Citations 0
Health Agencies Update
June 26, 2018

NIH-Sponsored Trial of Universal Influenza Vaccine

JAMA. 2018;319(24):2469. doi:10.1001/jama.2018.7886

The National Institute of Allergy and Infectious Diseases (NIAID) recently launched a phase 2 clinical trial of an experimental universal influenza vaccine.

Because seasonal influenza vaccines differ year to year to match the strains predicted to circulate in the upcoming season, people must be vaccinated annually. However, influenza viruses mutate constantly, which can affect the efficacy of seasonal vaccines. A universal flu vaccine could address these challenges by protecting against a variety of flu strains, rather than a select few.

×